HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoyuki Katayama Selected Research

HER2p63 peptide

5/2002Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoyuki Katayama Research Topics

Disease

17Neoplasms (Cancer)
01/2021 - 05/2002
13Disseminated Intravascular Coagulation
01/2019 - 04/2008
11Thrombosis (Thrombus)
09/2018 - 04/2008
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2018 - 11/2002
10Hemorrhage
07/2019 - 02/2009
7Inflammation (Inflammations)
10/2021 - 11/2008
7Thrombotic Microangiopathies
06/2019 - 01/2008
7Thrombocytopenia (Thrombopenia)
01/2019 - 05/2009
6Hemophilia A (Haemophilia)
06/2019 - 11/2017
6Fever (Fevers)
01/2019 - 08/2008
5Thrombotic Thrombocytopenic Purpura
06/2019 - 01/2008
5Venous Thrombosis (Deep-Vein Thrombosis)
05/2018 - 04/2008
5Venous Thromboembolism
01/2018 - 04/2008
5Neutropenia
01/2016 - 02/2009
5Leukemia
01/2015 - 03/2002
4Infections
09/2022 - 05/2010
4Breast Neoplasms (Breast Cancer)
01/2021 - 01/2014
4Multiple Myeloma
01/2020 - 01/2004
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020 - 01/2017
4Shock
02/2017 - 02/2009
4Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 08/2008
4Breakthrough Infections
11/2014 - 08/2008
3Lymphoma (Lymphomas)
03/2022 - 06/2018
3Esophageal Neoplasms (Esophageal Cancer)
11/2021 - 11/2009
3Fibrosis (Cirrhosis)
10/2021 - 06/2019
3Disease Progression
01/2020 - 09/2011
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2020 - 01/2016
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 08/2015
3Diarrhea
10/2019 - 01/2016
3Communicable Diseases (Infectious Diseases)
01/2019 - 10/2009
3Connective Tissue Diseases (Connective Tissue Disease)
09/2018 - 01/2016
3Carcinoma (Carcinomatosis)
04/2018 - 09/2011
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2017 - 02/2009
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 02/2002
3Liver Diseases (Liver Disease)
12/2014 - 01/2009
3Pneumonia (Pneumonitis)
11/2014 - 03/2002
2Sepsis (Septicemia)
01/2022 - 02/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2021 - 01/2014
2Colitis
10/2021 - 01/2014
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2020 - 04/2007
2Peripheral Nervous System Diseases (PNS Diseases)
05/2020 - 07/2010
2Esophageal Squamous Cell Carcinoma
04/2020 - 01/2016
2Acute Promyelocytic Leukemia
01/2020 - 01/2017
2Heart Arrest (Cardiac Arrest)
07/2019 - 06/2019
2Hematologic Diseases (Blood Diseases)
06/2019 - 08/2010
2Hemolytic-Uremic Syndrome
06/2019 - 01/2018
2Stomach Neoplasms (Stomach Cancer)
01/2019 - 09/2011
2Drug-Related Side Effects and Adverse Reactions
01/2019 - 07/2010
2Necrosis
04/2018 - 04/2013

Drug/Important Bio-Agent (IBA)

15Dacarbazine (DIC)FDA LinkGeneric
06/2019 - 04/2008
9Proteins (Proteins, Gene)FDA Link
04/2020 - 05/2002
8FibrinIBA
10/2018 - 06/2010
6Hemostatics (Antihemorrhagics)IBA
07/2019 - 02/2015
6Anti-Bacterial Agents (Antibiotics)IBA
02/2017 - 03/2002
5CytokinesIBA
10/2021 - 03/2010
5AntigensIBA
04/2020 - 03/2008
5fibrin fragment D (D-dimer)IBA
09/2018 - 04/2008
5von Willebrand FactorIBA
09/2018 - 01/2008
4Vincristine (Oncovin)FDA LinkGeneric
07/2021 - 04/2007
4Rituximab (Mabthera)FDA Link
05/2020 - 04/2008
4Imatinib Mesylate (Gleevec)FDA Link
01/2020 - 10/2004
4Interleukin-2 Receptors (IL 2 Receptor)IBA
06/2018 - 10/2012
4thiamine triphosphorate (TTP)IBA
01/2018 - 01/2008
4Prednisolone (Predate)FDA LinkGeneric
01/2017 - 02/2009
4Micafungin (FK463)FDA Link
11/2014 - 08/2008
3Methotrexate (Mexate)FDA LinkGeneric
07/2021 - 12/2019
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2020 - 05/2018
3Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2019
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 04/2007
3Fibrinogen (Factor I)FDA Link
01/2019 - 01/2014
3Indicators and Reagents (Reagents)IBA
01/2019 - 04/2007
3AnticoagulantsIBA
01/2019 - 01/2016
3AntithrombinsIBA
03/2017 - 02/2016
3Antifungal AgentsIBA
11/2014 - 02/2009
3EchinocandinsIBA
11/2014 - 08/2008
2AnthracyclinesIBA
10/2022 - 06/2018
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2021 - 04/2020
2Cisplatin (Platino)FDA LinkGeneric
11/2020 - 04/2018
2Prednisone (Sone)FDA LinkGeneric
05/2020 - 05/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2020 - 05/2018
2Cytochrome P-450 CYP3AIBA
05/2020 - 07/2010
2Peptides (Polypeptides)IBA
04/2020 - 05/2002
2Monoclonal AntibodiesIBA
04/2020 - 10/2016
2enhanced green fluorescent proteinIBA
04/2020 - 12/2019
2NivolumabIBA
01/2020 - 01/2019
2Bortezomib (Velcade)FDA Link
01/2020 - 07/2010
2emicizumabIBA
07/2019 - 11/2017
2EnzymesIBA
01/2019 - 08/2010
2AntibodiesIBA
01/2019 - 07/2018
2Inosine Triphosphate (ITP)IBA
01/2019 - 01/2016
2eculizumabFDA Link
11/2018 - 01/2018
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
09/2018 - 09/2017
2Bleomycin (Blenoxane)FDA LinkGeneric
05/2018 - 04/2018

Therapy/Procedure

29Therapeutics
10/2022 - 02/2002
12Drug Therapy (Chemotherapy)
05/2020 - 03/2002
4Transplantation
03/2022 - 08/2011
3Hematopoietic Stem Cell Transplantation
01/2022 - 11/2014
3Orthopedic Procedures
01/2018 - 11/2014
2Radiotherapy
07/2021 - 01/2020
2Chemoradiotherapy
06/2018 - 05/2016